RecruitingPHASE1, PHASE2NCT06137664

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PATH
Intervention
Novel oral poliomyelitis vaccine type 1 (nOPV1)(biological)
Enrollment
2400 target
Eligibility
45 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

Bio Farma, Indonesia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06137664 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials